Testing effectiveness (Phase 2)Study completedNCT01031836
What this trial is testing
Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.
Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 30